Clinical Trial Update: Effect of Sildenafil Citrate on Mid Luteal Phase Uterine Artery Blood Flow in Patients With Recurrent Pregnancy Loss [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating sildenafil citrate for improving mid-luteal uterine artery blood flow in recurrent pregnancy loss.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• Sildenafil citrate (Sildenafil citrate)

Snippet

Sponsor: Ain Shams University | Conditions: Recurrent Pregnancy Loss | Phase 2 | Status: COMPLETED